Chief Technology Officer
Kim Warren was most recently Chief Manufacturing and Technology Officer for AVROBIO, based in Cambridge, MA and Toronto, ON. She retired from this role in July 2020. AVROBIO is a clinical-stage company using lentiviral-based gene therapy and the patient’s own cells to restore normal gene function. Kim oversees all aspects of process development and manufacturing, including coordination of CDMOs globally. Her previous experience includes 10 years at Lonza, developing a services business to support GMP manufacturing of cell and gene therapies, and heading R&D at Cambrex, developing cell-based research products. She founded and ran Poietic Technologies, Inc., acquired by Cambrex in 1999. Kim has also held research positions in pharma and biotech.